BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 30326467)

  • 21. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia).
    Ferrandina G; Aristei C; Biondetti PR; Cananzi FCM; Casali P; Ciccarone F; Colombo N; Comandone A; Corvo' R; De Iaco P; Dei Tos AP; Donato V; Fiore M; Franchi ; Gadducci A; Gronchi A; Guerriero S; Infante A; Odicino F; Pirronti T; Quagliuolo V; Sanfilippo R; Testa AC; Zannoni GF; Scambia G; Lorusso D
    Eur J Cancer; 2020 Nov; 139():149-168. PubMed ID: 32992154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine Adenosarcoma.
    Pinto A; Howitt B
    Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Müllerian adenosarcoma of the uterus with low-grade sarcomatous overgrowth characterized by prominent hydropic change resulting in mimicry of a smooth muscle tumor.
    Wu RI; Schorge JO; Dal Cin P; Young RH; Oliva E
    Int J Gynecol Pathol; 2014 Nov; 33(6):573-80. PubMed ID: 25272296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mullerian adenosarcoma of the female genital tract.
    McCluggage WG
    Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine müllerian adenosarcoma with sarcomatous overgrowth and lung metastasis in a 25-year-old woman.
    Choi YJ; Jung MH; Park YK; Lee BY; Huh CY
    Eur J Gynaecol Oncol; 2011; 32(1):91-4. PubMed ID: 21446335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uterine adenosarcoma: an analysis on management, outcomes, and risk factors for recurrence.
    Carroll A; Ramirez PT; Westin SN; Soliman PT; Munsell MF; Nick AM; Schmeler KM; Klopp AH; Fleming ND
    Gynecol Oncol; 2014 Dec; 135(3):455-61. PubMed ID: 25449308
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mullerian adenosarcoma of the uterus with MASO: a case report of cervical adenosarcoma in a young female that never had sexual behavior.
    Chen JW; Huang YJ; Wang LL; Liu JJ; Shi MM; Li N
    BMC Womens Health; 2024 May; 24(1):308. PubMed ID: 38783282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Müllerian adenosarcoma of the uterus: report of a case with imprint cytology.
    Takeshima N; Tabata T; Nishida H; Arai Y; Tsuzuku M; Hirai Y; Yamauchi K; Hasumi K
    Acta Cytol; 2001; 45(4):613-6. PubMed ID: 11480728
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Primary extra-uterine and extra-ovarian mullerian adenosarcoma: case report and literature review.
    Mandato VD; Torricelli F; Mastrofilippo V; Valli R; Aguzzoli L; La Sala GB
    BMC Cancer; 2018 Feb; 18(1):134. PubMed ID: 29402239
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uterine adenosarcoma with rhabdomyosarcomatous overgrowth. Brief communication.
    Yilmaz F; Ozdemir N; Akalin T; Veral A; Dikmen Y; Erhan Y
    Eur J Gynaecol Oncol; 2000; 21(4):430-2. PubMed ID: 11055503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low grade Mullerian adenosarcoma of pouch of Douglas recurring as bilateral ovarian high grade Mullerian adenosarcoma with rhabdomyosarcomatous overgrowth after 11 years.
    Kumar S; Raza M; Tariq MU
    J Pak Med Assoc; 2018 Aug; 68(8):1263-1266. PubMed ID: 30108400
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosarcoma of the uterine body initially presenting as an interstitial small tumor of the uterus: a case report.
    Miyata H; Tsuji N; Jimi T; Butsuhara Y; Terakawa K; Nagano T
    Eur J Gynaecol Oncol; 2014; 35(4):473-6. PubMed ID: 25118497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late recurrence of uterine Mullerian adenosarcoma as heterologous sarcoma: Three recurrences in 8 months increasing in number and grade of sarcomatous components.
    Taçkin S; Bozaci EA; Sönmezer M; Ekinci C; Ortaç F
    Gynecol Oncol; 2006 Apr; 101(1):179-82. PubMed ID: 16325895
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imaging findings of uterine adenosarcoma with sarcomatous overgrowth: two case reports, emphasizing restricted diffusion on diffusion weighted imaging.
    Nakai G; Matsutani H; Yamada T; Ohmichi M; Yamamoto K; Osuga K
    BMC Womens Health; 2021 Dec; 21(1):416. PubMed ID: 34915866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Uterine Adenosarcoma in a Teen Ager.
    Wang Y; Teng Y; Li J; Yuan Y
    J Coll Physicians Surg Pak; 2022 Apr; 32(4):S18-S20. PubMed ID: 35633000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Feasibility of uterine preservation in the management of early-stage uterine adenosarcomas: a single institute experience.
    Lee YJ; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH
    World J Surg Oncol; 2017 Apr; 15(1):87. PubMed ID: 28424089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenosarcoma of Uterus- Rare Biphasic Malignant Tumor: A Case Report.
    Ghartimagar D; Shrestha B; Ghosh A; Shrestha MK; Shrestha J; Thapa S; Talwar OP
    JNMA J Nepal Med Assoc; 2021 Feb; 59(234):200-203. PubMed ID: 34506473
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastasizing uterine mullerian adenosarcoma in a young female: Diagnostic enigma.
    Patnayak R; Rukmangadha N; Architha P; Reddy GS; Lakshmi AY; Kannan T; Jena A
    Indian J Pathol Microbiol; 2018; 61(3):440-442. PubMed ID: 30004077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Adenosarcoma of the uterus: a case report].
    Fatnassi R; Amri F
    J Gynecol Obstet Biol Reprod (Paris); 2005 May; 34(3 Pt 1):270-2. PubMed ID: 16012388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.